Product
ES104
1 clinical trial
1 indication
Indication
Colorectal CancerClinical trial
Phase I/II Clinical Trial of ES104 in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer Who Have Failed Systemic TherapiesStatus: Active (not recruiting), Estimated PCD: 2026-05-31